Category: Markets
Published: 2026-06-28T20:01:47.000Z
Pfizer Inc.'s Chief International Commercial Officer, Alexandre de Germay, stated that China has surpassed Europe in pharmaceutical innovation and drug development. He highlighted that China accounts for 40% of global clinical oncology studies and offers faster, cheaper clinical development compared to Europe. De Germay noted that China produced more innovative medicines than Europe in 2024, emphasizing the competitive threat posed by China.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.